SEC Company Response from Viela Bio, Inc. (CIK 0001734517) — May 26, 2020
Viela Bio, Inc. (CIK 0001734517)
Date: May 26, 2020 · CIK: 0001734517 · Accession: 0001193125-20-150846
AI Filing Summary & Sentiment
File numbers found in text: 333-238678
Letter
Viela Bio, Inc.
One MedImmune Way
First Floor, Area Two
Gaithersburg, MD 20878
May 26, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Suzanne Hayes, Office of Healthcare & Insurance
Re:
Viela Bio, Inc.
Registration Statement on Form S-1
File No. 333-238678
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Viela Bio, Inc., a Delaware corporation (the “Registrant”), hereby respectfully requests that the effective date of the above-captioned registration statement on Form S-1 (Registration No. 333-238678) be accelerated so that the registration statement may become effective at 4:00 p.m., Eastern time, on Wednesday, May 27, 2020, or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff. This request for acceleration is subject, however, to your receiving a telephone call prior to such time from our legal counsel, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., confirming this request. The Registrant hereby authorizes John T. Rudy of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, to make such request on its behalf.
Please call John T. Rudy (617-348-3050) of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, with any comments or questions regarding this matter.
[Signature page follows]
Very truly yours,
VIELA BIO, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Viela Bio, Inc. One MedImmune Way First Floor, Area Two Gaithersburg, MD 20878 May 26, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Suzanne Hayes, Office of Healthcare & Insurance Re: Viela Bio, Inc. Registration Statement on Form S-1 File No. 333-238678 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Viela Bio, Inc., a Delaware corporation (the “Registrant”), hereby respectfully requests that the effective date of the above-captioned registration statement on Form S-1 (Registration No. 333-238678) be accelerated so that the registration statement may become effective at 4:00 p.m., Eastern time, on Wednesday, May 27, 2020, or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff. This request for acceleration is subject, however, to your receiving a telephone call prior to such time from our legal counsel, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., confirming this request. The Registrant hereby authorizes John T. Rudy of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, to make such request on its behalf. Please call John T. Rudy (617-348-3050) of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, with any comments or questions regarding this matter. [Signature page follows] Very truly yours, VIELA BIO, INC. /s/ Zhengbin (Bing) Yao, Ph.D. Zhengbin (Bing) Yao, Ph.D. Chairman, President and Chief Executive Officer cc: Securities and Exchange Commission Suzanne Hayes, Assistant Director Irene Paik Viela Bio, Inc. Zhengbin (Bing) Yao, Ph.D. Mitchell Chan Jim Kastenmayer, Ph.D., J.D. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Jonathan L. Kravetz John T. Rudy Ropes & Gray LLP Patrick O’Brien KPMG LLP Brian McDonald